Informaçao sobre o Autor

Семиглазов, В. Ф

Edição Seção Título Arquivo
Nº 1S (2009) Articles ANTIANGIOGENNYE PREPARATY V LEChENII RAKA MOLOChNOY ZhELEZY
Nº 1S (2009) Articles NEOAD\"YuVANTNAYa ENDOKRINOTERAPIYa RAKA MOLOChNOY ZhELEZY
Nº 18 (2012) Articles A new approach to the overcoming resistance to hormone therapy of breast cancer
Nº 18 (2012) Articles Adjuvant hormonal therapy in perimenopausal women with ER-positive breast cancer
Nº 8 (2013) Articles ChETYRE ASPEKTA AD\"YuVANTNOY TARGETNOY TERAPII HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Nº 8 (2013) Articles ROL' IMMUNOKON\"YuGATOV V TARGETNOY TERAPII ZLOKAChESTVENNYKh OPUKhOLEY
Nº 17 (2013) Articles Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy
Nº 4 (2014) Articles Rak molochnoy zhelezy i beremennost'
Nº 8 (2015) Articles KOMPLEKSNAYa TERAPIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Nº 8 (2016) Articles NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
Nº 17 (2016) Articles RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER"
Nº 17 (2016) Articles TAXANES IN THE TREATMENT OF BREAST CANCER
Nº 17 (2017) Articles De-escalation and escalation of treatment of patients with HER2-positive breast cancer
Nº 17 (2017) Articles New possibilities of the treatment of breast cancer: microtubule inhibitors
Nº 7 (2018) Articles GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER
Nº 12 (2018) Articles Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities
Volume 26, Nº 12 (2019) Articles Adjuvant and neoadjuvant therapy for (based on the materials of the 16th St. Gallen International Breast Cancer Conference)
Volume 27, Nº 7 (2020) Articles Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study
Volume 27, Nº 7 (2020) Articles Treatment of residual breast cancer
Volume 27, Nº 7 (2020) Articles Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors
Volume 27, Nº 11 (2020) Articles Neoadjuvant and postneoadjuvant treatment for triple negative breast cancer
Volume 27, Nº 11 (2020) Articles Endocrine resistance in breast cancer treatment
Volume 28, Nº 7 (2021) Articles Search for new prognostic and predictive markers of sensitivity to endocrine therapy, chemotherapy and immunotherapy of breast cancer
Volume 29, Nº 7 (2022) Articles Clinical immunology of breast cancer
Volume 29, Nº 7 (2022) Articles Predictive and prognostic role of tumor-infiltrating lymphocytes (TILs) in early triple-negative breast cancer
Volume 29, Nº 7 (2022) Articles Treatment of HER2-positive early (minimal) breast cancer
Volume 29, Nº 11/12 (2022) Articles The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Volume 29, Nº 11/12 (2022) Articles Ixabepilone in the treatment of breast cancer

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies